Abstract

• Youth with comorbid anxiety and depression are especially difficult to treat. • A new treatment combined strategies to manage comorbid anxiety and depression. • Treated youth showed significant reductions in diagnoses and life impairment. • No differences with waitlist were shown on self-reported symptoms. • Improvements were maintained for up to 12 months. Evidence suggests that adolescents with comorbid anxiety and depression are a high-risk group in terms of symptom severity, life quality and prognosis, with unique treatment needs compared to their peers who meet criteria for a single diagnosis. The current study evaluated the efficacy of a transdiagnostic treatment designed specifically to target shared mechanisms underlying comorbid anxiety and depression in adolescents. Eighty-two adolescents (12–17 years) with a concurrent diagnosis of an anxiety and a mood disorder were randomly allocated to either active treatment or wait-list. Effects on diagnoses, symptoms and life interference were assessed at post-treatment, 6- and 12-month follow-up based on reports from both the young person and parents. Compared to waitlist, treatment was associated with a significantly greater reduction in total number of diagnoses and clinician rated severity of diagnoses over time. Life interference also showed significantly greater improvement in active treatment compared to wait-list, however other self and parent-reported indicators improved significantly but similarly over time in both groups. Effects were maintained at 6- and 12-month follow up. The transdiagnostic package targeting common underlying mechanisms demonstrated reductions in anxiety and depression in adolescents on key measures, including diagnostic criteria and life interference and shows promise as an efficacious treatment for comorbid anxiety and depression in adolescents. The outcomes point to a valuable initial program for clinical use, although further development will be needed to strengthen effects.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call